Biotech

All Articles

Cullinan, after $25M offer, return bispecific to Port

.Cullinan Therapy was made an impression on good enough with Harbour BioMed's bispecific immune acti...

A better take a look at Brutal Biotech's Ferocious 15

.In this week's incident of "The Best Line," our experts're diving into Tough Biotech's annual Tough...

Lilly experiences phase 2 failure of tau-targeting med

.The confetti is actually still flying from Eli Lilly's celebration commemorating the approval of Al...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings as wel...

Lykos will certainly ask FDA to rethink its choice observing rejection of MDMA therapy for post-traumatic stress disorder

.Following a poor showing for Lykos Therapeutics' MDMA candidate for trauma at a current FDA advisor...

AN 2 halves headcount, quits period 3 trial after records disappoint

.AN2 Therapeutics is actually reassessing its organization in action to dull midphase data, swearing...

Merck pays for $700M for bispecific, snooping autoimmune opening and also possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying $700 million in advance to challenge Amgen in a blood cancer market. The o...

Gilead pays out J&ampJ $320M to go out licensing package for seladelpar

.Along With Gilead Sciences on the verge of an FDA decision for its own liver ailment medication sel...

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks can observe the business putting together tents at basecamp behind Eli Lilly in an ...

Entero giving up staff, vacating office and stopping R&ampD

.Bed mattress Liquidators has switched Entero Rehabs white colored as a slab. The collector purchase...